IRIS
MICIACCIA, MORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.820
AS - Asia 1.361
EU - Europa 1.071
SA - Sud America 306
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 53
OC - Oceania 27
Totale 4.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.708
IT - Italia 574
SG - Singapore 529
CN - Cina 267
BR - Brasile 229
HK - Hong Kong 176
RU - Federazione Russa 93
VN - Vietnam 89
CA - Canada 82
DE - Germania 78
GB - Regno Unito 57
IN - India 52
SE - Svezia 52
BD - Bangladesh 51
FR - Francia 46
JP - Giappone 33
NL - Olanda 28
AU - Australia 26
CH - Svizzera 26
ID - Indonesia 25
FI - Finlandia 24
TR - Turchia 23
AR - Argentina 20
EC - Ecuador 19
ES - Italia 16
MX - Messico 14
IQ - Iraq 13
KR - Corea 13
SA - Arabia Saudita 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
CO - Colombia 12
PL - Polonia 12
BE - Belgio 11
PH - Filippine 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
PK - Pakistan 9
CL - Cile 8
AT - Austria 7
IR - Iran 7
LT - Lituania 7
IL - Israele 6
VE - Venezuela 6
HU - Ungheria 5
IE - Irlanda 5
JM - Giamaica 5
PY - Paraguay 5
TW - Taiwan 5
EG - Egitto 4
KE - Kenya 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
TH - Thailandia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
SN - Senegal 3
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
MD - Moldavia 2
SC - Seychelles 2
TN - Tunisia 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GI - Gibilterra 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 4.640
Salva come PNG Salva come JPEG
Città #
Singapore 269
San Jose 267
Ashburn 251
Hong Kong 169
Beijing 96
Milan 83
Council Bluffs 80
Bari 73
Dallas 61
Sannicandro di Bari 57
New York 56
Los Angeles 51
Columbus 49
Chandler 48
Rome 41
Nyköping 39
Fairfield 37
Ho Chi Minh City 36
Santa Clara 34
Vancouver 29
Helsinki 24
São Paulo 23
Tokyo 22
Cambridge 21
Boardman 20
Falkenstein 20
Frankfurt am Main 18
Munich 18
Toronto 18
Houston 17
Lauterbourg 17
San Francisco 17
Seattle 16
Woodbridge 16
Bern 14
Denver 14
Jakarta 14
London 14
Buffalo 13
Catania 13
Taranto 13
Abidjan 12
Atlanta 12
Hanoi 12
Montreal 12
Naples 11
Bitonto 10
Brussels 10
Tashkent 10
Waltham 10
Warsaw 10
Wilmington 10
New Delhi 9
Nuremberg 9
Palermo 9
Phoenix 9
Shanghai 9
Brno 8
Chennai 8
Orem 8
Philadelphia 8
Santiago 8
West Lafayette 8
Ann Arbor 7
Belo Horizonte 7
Brooklyn 7
Burlington 7
Chicago 7
Chuncheon 7
City of London 7
Florence 7
Guayaquil 7
Johannesburg 7
Palo Alto 7
Bologna 6
Brisbane 6
Dalmine 6
Düsseldorf 6
Jeddah 6
Lawrence 6
Lecce 6
Mersin 6
Mexico City 6
Mumbai 6
Perth 6
Prineville 6
Quito 6
Riyadh 6
Stockholm 6
Sydney 6
Turin 6
Boston 5
Dearborn 5
Forest City 5
Illkirch-Graffenstaden 5
Istanbul 5
Madrid 5
Medellín 5
Moscow 5
Petaluma 5
Totale 2.624
Salva come PNG Salva come JPEG
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 261
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 193
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 178
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 165
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 143
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior 143
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 130
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 130
DECONSTRUCTING ONC201 TO DESIGN NEW MITOCHONDRIAL ClpP ACTIVATORS FOR PEDIATRIC H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 128
STRUCTURAL EVOLUTION OF ONC201-DERIVED COMPOUNDS TARGETING THE MITOCHONDRIAL PROTEASE CLPP FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA H3K27-ALTERED" 126
Three-dimensional structure of human cyclooxygenase (hCOX)-1 121
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery 118
Three-dimensional structure of human cyclooxygenase (hCOX)-1 114
Novel hClpP protease activators with potential anticancer activity in DIPG patients 113
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 112
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 106
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 102
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 102
TARGETING HUMAN MITOCHONDRIAL ClpP AS A NOVEL THERAPEUTIC APPROACH TO H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 102
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 101
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 97
Ovine COX-1 Isoenzyme Bio-production 97
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 96
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 94
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges 94
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 94
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 94
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 89
Structure-activity relationships of piperazine-2-one derivatives as novel human ClpP activators 87
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug. 86
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 86
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 81
Inside circular economy challenges: “green” application to valorise olive mill wastewater 78
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 70
Design and synthesis of new [4,5-b] and [4,5-c] imidazopyridines as potential fluorophores/inhibitors for Human Cyclooxygenase-1. 70
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy 70
The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 cells 69
Structural simplification of imipridones to speed up the knowledge on the nature of the interactions with the human ClpP, a mitochondrial protease strictly linked to DIPG 69
Mitochondrial Protease ClpP: Cancer Marker and Drug Target 68
KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation 67
Potassium channels and TRPV1 modulators on SU-DIPG-36 and SU-DIPG-50 cells: in vitro effects and channel currents characterization 65
Can Focused Ultrasound Overcome the Failure of Chemotherapy in Treating Pediatric Diffuse Intrinsic Pontine Glioma Due to a Blood–Brain Barrier Obstacle? 64
Harmaline as novel mitochondrial human ClpP activator for the treatment of pediatric DIPG 54
Exosomes in Ovarian Cancer: Towards Precision Oncology 54
ONC201-derived Tetrahydropyridopyrimidindiones as powerful ClpP protease activators to tackle diffuse midline glioma 51
Effect of microbial fermentation on functional traits and volatiloma profile of pâté olive cake 46
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 46
Triazole-benzodiazepine derivatives: One-pot synthesis, characterization, hirshfeld surface analysis, and computational insights into anticancer potential as KIF11 inhibitors 30
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive 28
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood–Brain Barrier Permeability and Neuroprotective Chelation Therapy 23
Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes 15
TARGETING HUMAN MITOCHONDRIAL ClpP: A THRILLING CHALLENGE FOR NEW THERAPEUTIC STRATEGIES IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA 9
Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines 9
Totale 4.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202259 0 0 1 2 2 5 2 14 3 8 9 13
2022/2023152 8 19 17 6 18 21 4 27 19 4 6 3
2023/2024295 4 14 14 24 26 18 16 7 95 35 16 26
2024/2025924 41 14 40 35 68 78 150 86 47 60 88 217
2025/20262.723 274 105 183 263 333 154 299 126 363 273 164 186
2026/2027481 255 134 92 0 0 0 0 0 0 0 0 0
Totale 4.838